Started in 1999, India-based GenAxy Scientific with its corporate office in New Delhi and head office in Solan, has made a mark in offering wide product range in plasticware and instrumentation.

Equipped with customer friendly, motivated, well learned, qualified and trained personnel in all the departments, and well organized distribution channels comprising of five branch offices and 184 distributors, the company in 2011-12 recorded a revenue of $6.8 million (Rs34 crore) and has shown consistent growth over the period of time.

Its sister concern Future Biosciences too has made significant development in lab consumables business by registering close to $1 million (Rs5 crore) revenue in the last fiscal. Mr Navneet Trehan, CEO, GenAxy Scientific, talked about the company's performance, product additions, future outlook and biosupplier market trends.

How do you measure the performance of GenAxy Scientific in the last year? How have things unfolded for Future Biosciences?
The performance of GenAxy in the past year has been excellent. New product lines and extended range of existing products has increased our credibility to many folds. We started offering robotic systems with high-end customized and innovative solutions. This venture is in collaboration with the state-of-the-art technology from Canada-based Aurora Biomed, Taiwan-based and Arise.

Started in 2005, Future Bioscience (FBS) has made its presence felt in the Indian market. The company has been ranked among the top 50 companies in India in the past two years. Strategic and strong tie-ups with Bisicion, Cleaver Scientific, Grant, and TPP have made FBS a reliable supplier to the scientific fraternity, besides the launch of indigenous range of plastic consumables.